HeartVista
Heart Vista is a medical technology company that develops intelligent software to streamline MRI exams, particularly focusing on cardiac MRI (CMR). Their flagship product, Vista Cardiac, automates and simplifies the image acquisition process, enabling any clinician to perform accurate, high-quality scans quickly and consistently. The company aims to make advanced MRI technology accessible to all patients and healthcare providers, with plans to expand their offerings to other anatomical areas. With FDA clearance and collaborations with leading cardiology hospitals, Heart Vista is positioned to transform cardiac imaging and improve patient care across the healthcare system.
HeartVista
Heart Vista is a medical technology company that develops intelligent software to streamline MRI exams, particularly focusing on cardiac MRI (CMR). Their flagship product, Vista Cardiac, automates and simplifies the image acquisition process, enabling any clinician to perform accurate, high-quality scans quickly and consistently. The company aims to make advanced MRI technology accessible to all patients and healthcare providers, with plans to expand their offerings to other anatomical areas. With FDA clearance and collaborations with leading cardiology hospitals, Heart Vista is positioned to transform cardiac imaging and improve patient care across the healthcare system.
TL;DR
Product: AI-driven software that automates and simplifies cardiac MRI (One Click MRI / Vista Cardiac)
Stage / Funding: Series A announced Apr 28, 2020 (~$8.65M)
HQ: San Francisco Bay Area (Los Altos / Palo Alto)
Team size: Reported 11–50 employees (profiles also cite 25)
Regulatory status: FDA clearance for cardiac product (stated in company snapshot)
Company Overview
Problem Domain
Cardiac MRI workflow complexity and limited accessibility of advanced MRI imaging
Industry
Medical technology / Health care / Medical device software
Funding Track Record
8,650,000.00
Investor Signal
“Backed by venture investors including Khosla Ventures, Open Field Capital, Leslie Ventures, Jeff Rothschild”